These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9707100)
1. Coumarin chemoprotection against aflatoxin B1-induced gene mutation in a mammalian cell system: a species difference in mutagen activation and protection with chick embryo and rat liver S9. Goeger DE; Anderson KE; Hsie AW Environ Mol Mutagen; 1998; 32(1):64-74. PubMed ID: 9707100 [TBL] [Abstract][Full Text] [Related]
2. Co-mutagenicity of coumarin (1,2-benzopyrone) with aflatoxin B1 and human liver S9 in mammalian cells. Goeger DE; Hsie AW; Anderson KE Food Chem Toxicol; 1999 Jun; 37(6):581-9. PubMed ID: 10478826 [TBL] [Abstract][Full Text] [Related]
3. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole. Choi CY; Park SH; Park EH; Cha YN J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539 [TBL] [Abstract][Full Text] [Related]
4. Piperine inhibits aflatoxin B1-induced cytotoxicity and genotoxicity in V79 Chinese hamster cells genetically engineered to express rat cytochrome P4502B1. Reen RK; Wiebel FJ; Singh J J Ethnopharmacol; 1997 Nov; 58(3):165-73. PubMed ID: 9421252 [TBL] [Abstract][Full Text] [Related]
5. Cytosol is required for the modulation by dietary casein of the hepatic microsomal activation of aflatoxin B1 to mutagenic metabolites detectable in Salmonella. Woodall GM; Dauterman WC; Hagler WM; DeMarini DM Mutagenesis; 1999 Jul; 14(4):365-73. PubMed ID: 10390503 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111 [TBL] [Abstract][Full Text] [Related]
7. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. II. Studies with induced rat liver S9. Woodall GM; Dauterman WC; DeMarini DM Mutat Res; 1996 Jun; 360(2):127-43. PubMed ID: 8649465 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
9. Sister chromatid exchange studies in the chick embryo and neonate: actions of mutagens in a developing system. Bloom SE Basic Life Sci; 1984; 29 Pt B():509-33. PubMed ID: 6397191 [TBL] [Abstract][Full Text] [Related]
10. Investigations on DNA binding in rat liver and in Salmonella and on mutagenicity in the Ames test by emodin, a natural anthraquinone. Bösch R; Friederich U; Lutz WK; Brocker E; Bachmann M; Schlatter C Mutat Res; 1987 Jul; 188(3):161-8. PubMed ID: 3110611 [TBL] [Abstract][Full Text] [Related]
11. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. I. Studies with noninduced rat liver S9. Woodall GM; Dauterman WC; DeMarini DM Mutat Res; 1996 Jun; 360(2):115-26. PubMed ID: 8649464 [TBL] [Abstract][Full Text] [Related]
12. Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells. Pelkonen P; Lang MA; Wild CP; Negishi M; Juvonen RO Eur J Pharmacol; 1994 Nov; 292(1):67-73. PubMed ID: 7867691 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of dexamethasone-induced cytochrome P450-mediated mutagenicity and metabolism of aflatoxin B1 by Chinese medicinal herbs. Wong BY; Lau BH; Yamasaki T; Teel RW Eur J Cancer Prev; 1993 Jul; 2(4):351-6. PubMed ID: 8358288 [TBL] [Abstract][Full Text] [Related]
14. Protection against aflatoxin-B1-induced liver mutagenesis by Scutellaria baicalensis. de Boer JG; Quiney B; Walter PB; Thomas C; Hodgson K; Murch SJ; Saxena PK Mutat Res; 2005 Oct; 578(1-2):15-22. PubMed ID: 16202794 [TBL] [Abstract][Full Text] [Related]
15. Acrylamide as an inducer of metabolic activation system (S9) in rats. el-Din AY; al-Maskati HA; Mohamed AY; Dairi MG Mutat Res; 1993 Jul; 300(2):91-7. PubMed ID: 7685498 [TBL] [Abstract][Full Text] [Related]
16. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9. Johnson TE; Umbenhauer DR; Galloway SM Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047 [TBL] [Abstract][Full Text] [Related]
17. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice. Irwin RD Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105 [TBL] [Abstract][Full Text] [Related]
18. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261 [TBL] [Abstract][Full Text] [Related]
19. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention. Buetler TM; Bammler TK; Hayes JD; Eaton DL Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of ellagic acid on the direct-acting mutagenicity of aflatoxin B1 in the Salmonella microsuspension assay. Loarca-Piña G; Kuzmicky PA; de Mejía EG; Kado NY Mutat Res; 1998 Feb; 398(1-2):183-7. PubMed ID: 9626978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]